1. Home
  2. LITB vs INKT Comparison

LITB vs INKT Comparison

Compare LITB & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LightInTheBox Holding Co. Ltd.

LITB

LightInTheBox Holding Co. Ltd.

HOLD

Current Price

$2.39

Market Cap

43.0M

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$12.12

Market Cap

51.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LITB
INKT
Founded
2007
2017
Country
Singapore
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.0M
51.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LITB
INKT
Price
$2.39
$12.12
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
19.5K
20.6K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$219,105,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$4.56
52 Week High
$4.17
$76.00

Technical Indicators

Market Signals
Indicator
LITB
INKT
Relative Strength Index (RSI) 58.92 50.56
Support Level $1.73 $11.33
Resistance Level $2.91 $12.31
Average True Range (ATR) 0.31 0.72
MACD 0.10 0.07
Stochastic Oscillator 59.38 48.09

Price Performance

Historical Comparison
LITB
INKT

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: